BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15735860)

  • 41. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rare tumor of the tongue in a child: alveolar soft part sarcoma.
    Rodríguez-Velasco A; Fermán-Cano F; Cerecedo-Díaz F
    Pediatr Dev Pathol; 2009; 12(2):147-51. PubMed ID: 18630993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Alveolar soft part sarcoma: a clinicopathologic analysis of 48 cases].
    Cheng J; Tu P; Wang J; He Y; Yu B; Rao Q; Zhou X; Shi Q
    Zhonghua Bing Li Xue Za Zhi; 2016 Jan; 45(1):16-20. PubMed ID: 26791548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alveolar soft part sarcoma 'revisited': clinicopathological review of 47 cases from a tertiary cancer referral centre, including immunohistochemical expression of TFE3 in 22 cases and 21 other tumours.
    Rekhi B; Ingle A; Agarwal M; Puri A; Laskar S; Jambhekar NA
    Pathology; 2012 Jan; 44(1):11-7. PubMed ID: 22173238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study.
    Sharain RF; Gown AM; Greipp PT; Folpe AL
    Hum Pathol; 2019 May; 87():65-74. PubMed ID: 30851332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary Alveolar Soft-Part Sarcoma (ASPS) of the Prostate: Report of a Deceptive Case.
    Daneshpajouhnejad P; Morrison C; Zhao X; Daniel RE; Schwartz L; Cooper K; Zhang P; Lal P
    Int J Surg Pathol; 2023 Oct; 31(7):1359-1363. PubMed ID: 36694389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of alveolar soft part sarcoma of the pleura.
    Ju HU; Seo KW; Jegal Y; Ahn JJ; Lee YJ; Kim YM; Oak C; Ra SW
    J Korean Med Sci; 2013 Feb; 28(2):331-5. PubMed ID: 23400231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The management of pseudomyogenic hemangioendothelioma of the foot: A case report and review of the literature.
    Pranteda G; Magri F; Muscianese M; Pigliacelli F; D'Arino A; Federico A; Pranteda G; Bartolazzi A
    Dermatol Ther; 2018 Nov; 31(6):e12725. PubMed ID: 30239066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alveolar Soft Part Sarcoma of the Uterus: Clinicopathological and Molecular Characteristics.
    Lee Y; Na K; Woo HY; Kim HS
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary Thyroid Gland Alveolar Soft Part Sarcoma.
    Whaley RD; Thompson LDR
    Head Neck Pathol; 2020 Sep; 14(3):701-706. PubMed ID: 31782115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature.
    Hasegawa K; Ichikawa R; Ishii R; Oe S; Kato R; Kobayashi Y; Kuroda M; Udagawa Y
    Int J Clin Oncol; 2011 Dec; 16(6):751-8. PubMed ID: 21519815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
    Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
    Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.
    Vistica DT; Hollingshead M; Borgel SD; Kenney S; Stockwin LH; Raffeld M; Schrump DS; Burkett S; Stone G; Butcher DO; Shoemaker RH
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):561-70. PubMed ID: 19636271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alveolar soft part sarcoma: a clinicopathological and immunohistochemical analysis of 26 cases emphasizing risk factors and prognosis.
    Zhang Y; Huang Y; Qin Y; Yang N; Yang P; Li N; Feng Z
    Diagn Pathol; 2024 Jan; 19(1):23. PubMed ID: 38291475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
    Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary Alveolar Soft-Part Sarcoma of the Lung: A Case Report.
    Zhao J; Peng J; Liu J; Deng Q; Pang X
    Int J Surg Pathol; 2023 Feb; 31(1):98-103. PubMed ID: 35521911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fine-needle aspiration cytology of alveolar soft-part sarcoma.
    Shabb N; Sneige N; Fanning CV; Dekmezian R
    Diagn Cytopathol; 1991; 7(3):293-8. PubMed ID: 1879268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alveolar soft part sarcoma in a child - a case report.
    Bartoš V; Sejnová D; Skálová A; Béder I
    Klin Onkol; 2023; 36(4):396-400. PubMed ID: 37877532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.
    Cassidy M; Loftus B; Whelan A; Sabt B; Hickey D; Henry K; Leader M
    Virchows Arch; 1994; 424(6):635-40. PubMed ID: 7519954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms.
    Guérin R; Menard AL; Angot E; Piton N; Vera P; Schwarz L; Sabourin JC; Laé M; Thiébaut PA
    Diagn Pathol; 2024 Apr; 19(1):62. PubMed ID: 38643139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.